Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Cancer Chemotherapy and Pharmacology|February 16, 2022
Cabozantinib with or without Panitumumab for RAS wild-type metastatic colorectal cancer: impact of MET amplification on clinical outcomes and circulating biomarkersJingquan Jia, Lauren Howard, Yingmiao Liu, et al.
Nucleic Acids Research|July 21, 2006
H1 RNA polymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activityJing Mi, Xiuwu Zhang, Zahid N Rabbani, et al.
Angiogenesis|May 24, 2021
Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance)Julia C F Quintanilha, Yingmiao Liu, Amy S Etheridge, et al.
Biochemical and Biophysical Research Communications|March 27, 2007
Reversal of cocaine sensitization-induced behavioral sensitization normalizes GAD67 and GABAA receptor alpha2 subunit expression, and PKC zeta activityQiang Chen, Tong H Lee, William C Wetsel, et al.
Cancer Medicine|May 2, 2013
Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumabYingmiao Liu, Mark D Starr, Anuradha Bulusu, et al.
Nature Communications|May 5, 2017
CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicumYu Jiang, Fenghui Qian, Junjie Yang, et al.
Cancer|May 27, 2020
A multi-institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancerRichard D Kim, Hanna K Sanoff, Andrew S Poklepovic, et al.
Journal of Cancer Research and Clinical Oncology|April 26, 2019
Neutrophil extracellular traps enhance procoagulant activity in patients with oral squamous cell carcinomaBaorong Li, Yingmiao Liu, Tenglong Hu, et al.
Journal of Neurochemistry|December 3, 2008
Targeting inhibition of GluR1 Ser845 phosphorylation with an RNA aptamer that blocks AMPA receptor traffickingYingmiao Liu, Qi-An Sun, Qiang Chen, et al.
Molecular Cancer Therapeutics|July 13, 2018
Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105Yingmiao Liu, Mark D Starr, John C Brady, et al.
Pageof 6